Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew C. Orth currently holds 77,979 shares of Krystal Biotech, Inc. (KRYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew C. Orth has been a net seller of KRYS stock. They have purchased $0 and sold $1.6M worth of shares.
Andrew C. Orth's most recent insider trade was on Oct 19, 2026, when they sold 77,979 shares at $0.00 per share.
Andrew C. Orth serves as Executive at Krystal Biotech, Inc. (KRYS). They have executed 5 insider transactions totaling $1.6M over their tenure at the company.
Andrew C. Orth holds the position of Executive at Krystal Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Andrew C. Orth has shown a selling trading pattern, with $0 in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew C. Orth was on Jun 9, 2023, when they sold $890.5K worth of KRYS shares. This transaction involved 6,906 shares at $128.94 per share.
Andrew C. Orth currently owns 77,979 shares of Krystal Biotech, Inc. (KRYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew C. Orth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew C. Orth has 5 Form 4 filings on record as an insider at Krystal Biotech, Inc..
Set alerts for Andrew C. Orth and 40,000+ other insiders.